Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Novavax Inc (NVAX)
Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Does This Message From Moderna Mean Bad News for Novavax?

So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market.

MRNA : 100.27 (+0.83%)
NVAX : 7.16 (-0.42%)
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10

These stocks look cheap right now -- if the companies can meet their goals.

PFE : 32.09 (-0.03%)
NVAX : 7.16 (-0.42%)
NVTA : 0.6075 (-3.17%)
Why COVID Vaccine Demand Might Not Be That Strong

COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.

NVAX : 7.16 (-0.42%)
MRNA : 100.27 (+0.83%)
Novavax Is a Step Behind, Again. Should You Be Worried?

The FDA still is reviewing Novavax's updated vaccine candidate.

PFE : 32.09 (-0.03%)
NVAX : 7.16 (-0.42%)
Up 20% in 1 Month, Is This Stock a Buy?

As Covid cases rise, Novavax is getting more attention again. But will the momentum last?

NVAX : 7.16 (-0.42%)
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Novavax...

NVAX : 7.16 (-0.42%)
Novavax to Participate in Upcoming September Conferences

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will...

NVAX : 7.16 (-0.42%)
3 Stocks to Buy For the COVID Resurgence

The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting

MRNA : 100.27 (+0.83%)
NVAX : 7.16 (-0.42%)
PFE : 32.09 (-0.03%)
ALNY : 174.03 (-1.60%)
ABUS : 2.00 (-0.50%)
BNTX : 102.03 (-1.06%)
CVAC : 6.50 (-8.58%)
LGF-A : N/A (unch)
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?

Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition.

PFE : 32.09 (-0.03%)
NVAX : 7.16 (-0.42%)
Why Novavax Stock Rocketed 10% Higher Today

The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House.

PFE : 32.09 (-0.03%)
NVAX : 7.16 (-0.42%)

Barchart Exclusives

Down 13% from 52-Week Highs, Is Amazon Stock a Buy Now?
Amazon stock is down more than 13% from the 52-week highs that it hit earlier this month. Why is AMZN stock dropping, and should you buy the dip? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar